Dasatinib Monohydrate Powder: Advanced Kinase Inhibitor for CML Treatment

Explore the power of Dasatinib Monohydrate Powder, a critical component in modern leukemia therapy.

Get a Quote & Sample

Key Advantages Offered

Targeted Therapy

Dasatinib powder is a potent kinase inhibitor that specifically targets BCR-ABL and SRC family kinases, offering a precise approach to combatting leukemia.

Overcoming Resistance

Our Dasatinib monohydrate raw powder is instrumental in overcoming resistance to existing treatments, making it a vital pharmaceutical intermediate.

Comprehensive Efficacy

This anticancer API Dasatinib Monohydrate has demonstrated efficacy in preclinical models, preventing disease progression and prolonging survival in various CML phases.

Key Applications

Chronic Myeloid Leukemia (CML) Treatment

Utilize Dasatinib powder for leukemia treatment in adult patients who have developed resistance or intolerance to prior imatinib mesylate regimens.

Oncology Drug Development

Employ this advanced antineoplastic agent as a critical component in the research and development of new oncology drugs.

Pharmaceutical Research

Source high-quality Dasatinib powder wholesale for your laboratory's pharmaceutical research and compound analysis.

API Manufacturing

Integrate our Dasatinib monohydrate raw powder into your manufacturing processes for active pharmaceutical ingredients.